United States: Weekly Washington Healthcare Update - August 25, 2014

Last Updated: September 2 2014
Article by Stephanie A. Kennan and Brian J. Looser

This Week: CMS continues work on Open Payment system... CMS releases guidance on training and certification for ACA Navigators... Treasury Inspector General describes IRS difficulty in determining who has paid medical device excise tax



Chairman Brady Releases Medicare Fraud Draft

On Aug. 7, 2014, Ways and Means Health Subcommittee Chairman Kevin Brady (R-TX) released a discussion draft of legislation entitled "The Protecting the Integrity of Medicare Act of 2014" (PIMA). PIMA focuses on addressing weaknesses in the Medicare program that have led to considerable waste, fraud and abuse, estimated to be as high as 10 percent of the $574 billion program. The draft consists of an assortment of specific policy items championed by various members of the committee, including a provision long advocated by Social Security Subcommittee Chairman Sam Johnson (R-TX) to remove Social Security numbers from beneficiaries' Medicare cards. In total, Brady's draft squeezes 25 individual sections into just 58 pages of legislative text. Though the focus of the draft language is to fight fraud within Medicare, provisions aimed at shoring up Medicaid and the Children's Health Insurance Program (CHIP) are included as well. Specifically, the draft would allow Medicaid fraud control units to investigate and prosecute complaints of abuse and neglect of Medicaid patients in home and community-based facilities. It would also provide the Health and Human Services secretary greater flexibility in how available resources are used to protect Medicaid from fraud, waste and abuse. Industry stakeholders are asked to submit comments or questions on the draft to nyu@mail.house.gov by Sept. 1.


State Work Period -- No Legislative Activity


CMS: Open Payment Verification System Repaired; Deadline Extended for Physician Payment Review

CMS announced Aug. 15 that the Open Payment verification system site is back online following a 12-day suspension. The suspension was as a result of an investigation following a physician complaint that "manufacturers and group purchasing organizations (GPO) [had] submitted intermingled data, such as wrong state license number or national provider identifier (NPI) for physicians with the same last and first names," an Aug. 15 CMS email to physicians said. The Open Payments program, a result of the Physician Payments Sunshine Act, mandates that GPOs and manufacturers of medical supplies, devices and pharmaceuticals report certain physician or teaching hospital payment information to CMS. At the end of July CMS began allowing physicians to log on to the CMS site to review disclosures on themselves and report inaccuracies. As a result of the site suspension, physicians now have an extended deadline of Sept. 8 to review reported payment information submitted for them from August 2013 through December 2013. Worth noting, this is not the first time the program has been criticized. Physicians have already cited difficulty registering with the system as well as issues with the accuracy of reported data. Following the three-week physician review period, CMS says that despite the unexpected delay, payment data will be publically available no later than Sept. 30.

For more information please see the official CMS announcement.

CMS: Guidance Released on Training and Certification for ACA Navigators and Other Assisters

On Aug. 15, CMS issued official guidance on the training and certification of "navigators" and other certified application counselors and assisters in the Affordable Care Act (ACA) marketplaces. This guidance comes in preparation for 2015 open enrollment in the individual federally run or state partnership exchanges beginning on Nov. 15, 2014. The bulletin outlines a 20-hour training regimen for certified navigators as well as a 5- to 10-hour training process for certified application counselors. Starting in September, official training through the Medicare Learning Network (MLN) will be available for the federally facilitated marketplace enhancements; the new official training also details more specific information on immigration, deriving particular household income scenarios, assistance to survivors of domestic violence and enrolling college students. According to the bulletin, all current assisters seeking recertification as well as new assisters will be required to take the new training on the MLN website, which will be taken down for several weeks and reprogramed to prepare for the new requirements.

OMB: Final Medicare Fraud Rule Under Review

Last week, CMS sent a final rule to the Office of Management and Budget (OMB) implementing several provider enrollment policies intended to combat fraud on the part of medical suppliers, such as expanding the instances in which a felony conviction can serve as a basis for denial or revocation of a provider's or supplier's enrollment. In addition, the final rule would change the Incentive Reward Program potential reward amount for information on individuals and entities who are engaging or have engaged in acts or omissions that resulted in the imposition of a sanction from 10 percent of the overpayments recovered in the case or $1,000, whichever is less, to 15 percent of the final amount collected applied to the first $66,000,000 for the sanctionable conduct.


Following Audit, CMS Halts an Ohio Medicare Advantage Provider's Plan Enrollment

On Aug. 11, CMS issued a letter to SummaCare Inc., an Akron, Ohio-based Medicare Advantage managed care provider, suspending all new enrollment and marketing activities. Citing multiple, serious violations, Centers for Medicare and Medicaid Services (CMS) Director of Medicare Part C and D Oversight and Enforcement Gerard Mulchahy said in his letter that these problems posed "a serious threat to the health and safety of enrollees... [stemming from the] ineffective monitoring and oversight" of the plan's pharmacy benefit manager. CMS said the 38 violations resulted in Medicare beneficiaries' experiencing delays or denials of medications and services and increased out-of-pocket costs. The sanctions resulted from a routine CMS audit of SummaCare's Medicare operations from June 2 to June 13, and 25 of the 38 violations involved Medicare Part D. While the original deadline for corrective action was mandated for Aug. 18, CMS has extended the deadline until Sept. 5 for the company to submit its plans to fix how it handles consumer appeals and grievances. Worth noting, CMS said the federal action does not affect coverage or benefits for current enrollees, but that the company is required to alert all enrollees about the sanctions. SummaCare is Summit County's largest Medicare managed-care plan, with about 16,500 enrollees from Summit County and more than 33,000 in 41 counties in the northern half of Ohio.


Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015

CMS released its proposal for the 2015 Medicare physician fee schedule on July 3 with suggested changes relating to Chronic Care Management (CCM) and Accountable Care Organizations (ACO). Medicare doctors who provide CCM services may be required starting in 2015 to use an electronic health record or other health information exchange platform to ensure their patients" care plans are electronically accessible to any provider caring for those patients. Medicare providers would also be required to use electronic health records certified under the Office of the National Coordinator for Health Information Technology"s certification program as having the capabilities to capture and report CCM data. ACOs were also addressed in the new fee schedule, as the proposed rule would increase the number of ACO quality measures with an increased focus on outcomes. Under the proposal, the total number of measures for quality reporting would increase from 33 to 37. Under the Medicare Shared Savings Program (MSSP), ACOs must meet certain quality targets to claim shared savings bonuses. Specifically, new measures would be added to focus on avoidable admissions for patients with multiple chronic conditions, heart failure and diabetes; depression remission; all-cause readmissions to a skilled nursing facility; and stewardship of patient resources, the agency said. The agency added that the existing composite measures for diabetes and coronary artery disease would also be updated. Comments must be received by Sept. 2, 2014.

Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Physician-Owned Hospitals: Data Sources for Expansion Exception; Physician Certification of Inpatient Hospital Services; Medicare Advantage Organizations and Part D Sponsors: Appeals Process for Overpayments Associated with Submitted Data

CMS has issued a proposed rule that would revise the Medicare hospital outpatient prospective payment system (OPPS) and the Medicare ambulatory surgical center (ASC) payment system for CY 2015 to implement applicable statutory requirements and changes arising from continuing experience with these systems. The proposed rule describes the proposed changes to the amounts and factors used to determine the payment rates for Medicare services paid under the OPPS and those paid under the ASC payment system. In addition, this proposed rule would update and refine the requirements for the Hospital Outpatient Quality Reporting (OQR) Program and the ASC Quality Reporting (ASCQR) Program.

CMS is also proposing changes to the data sources used for expansion requests for physician-owned hospitals under the physician self-referral regulations; changes to the underlying authority for the requirement of an admission order for all hospital inpatient admissions and changes to require physician certification for hospital inpatient admissions only for long-stay cases and outlier cases; and changes to establish a three-level appeals process for Medicare Advantage (MA) organizations and Part D sponsors that would be applicable to CMS-identified overpayments associated with data submitted by these organizations and sponsors. Comments must be received by Sept. 2, 2014.

Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies

This rule proposes to update and make revisions to the End-Stage Renal Disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2015. This rule also proposes to set forth requirements for the ESRD quality incentive program (QIP), including payment years (PYs) 2017 and 2018. This rule also proposes to make a technical correction to remove outdated terms and definitions. In addition, this rule proposes to set forth the methodology for adjusting Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule payment amounts using information from the Medicare DMEPOS Competitive Bidding Program (CBP); make alternative payment rules for DME and enteral nutrition under the Medicare DMEPOS CBP; clarify the statutory Medicare hearing aid coverage exclusion and specify devices not subject to the hearing aid exclusion; update the definition of minimal self-adjustment regarding what specialized training is needed by suppliers to provide custom fitting services if they are not certified orthotists; clarify the Change of Ownership (CHOW) and provides for an exception to the current requirements; revise the appeal provisions for termination of a contract and notification to beneficiaries under the Medicare DMEPOS CBP, and add a technical change related to submitting bids for infusion drugs under the Medicare DMEPOS CBP. Comments must be received by Sept. 2, 2014.


TIGTA: IRS Cannot Determine Who Is Not Paying Device Tax

On Aug. 19, the Treasury Inspector General for Tax Administration (TIGTA) released a report detailing information on how the Internal Revenue Service (IRS) is having difficulty determining which manufacturers are obligated to pay the medical device tax. Under the Affordable Care Act (ACA), nonexempt medical device businesses, including manufacturers, producers and importers, are required to pay an excise tax equaling 2.3 percent on the sales price for medical devices sold. TIGTA found that the biggest concern for identifying mandated device taxpayers stems from the reality that IRS relies on a database of registered medical device manufacturers administered by the Food and Drug Administration (FDA) and that FDA-collected data "cannot be definitively used to identify manufacturers subject to the medical device tax reporting and payment requirements." Likewise, there are several specific exemptions, safe harbors and retail specifications such that not all businesses registered with the FDA are engaged in taxable medical devices. Also of note, TIGTA found that both the number of quarterly federal excise tax returns and the amount of revenue being reported (a difference of approximately $286.6 million) are below initial IRS estimates. Finally, TIGTA found that IRS also cannot ensure the accuracy of existing medical device excise tax figures reported, identifying $117.8 million in discrepancies in the excise tax amount captured by the IRS. As part of the report, TIGRA provided several recommendations for IRS to improve collection and identification of device taxpayers, including reviewing the 276 tax returns to determine the proper excise tax owed, establishing a process for verifying the accuracy of tax amounts for paper-filed Forms 720, and initiating a process to correspond with taxpayers to obtain missing taxable sales or tax amounts.

OIG: Nursing Facilities' Compliance with Federal Regulations for Reporting Allegations of Abuse or Neglect

According to a report released by the HHS-OIG on Aug. 15, 85 percent of nursing facilities reported at least one allegation of abuse or neglect in 2012. Additionally, 76 percent of nursing facilities maintained policies that address Federal regulations for reporting both allegations of abuse or neglect and investigation results. Further, 61 percent of nursing facilities had documentation supporting the facilities' compliance with both Federal regulations under Section 1150B of the Social Security Act. Lastly, 53 percent of allegations of abuse or neglect and the subsequent investigation results were reported, as Federally required. OIG recommends that CMS ensure that nursing facilities: (1) maintain policies related to reporting allegations of abuse or neglect; (2) notify covered individuals of their obligation to report reasonable suspicions of crimes; and (3) report allegations of abuse or neglect and investigation results in a timely manner and to the appropriate individuals, as required. CMS concurred with all three of recommendations.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions